Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by frewil11on Feb 12, 2022 9:31am
375 Views
Post# 34422972

MAKING PROGRESS

MAKING PROGRESSI do believe the numbers are starting to get better , rough estimate here , 15 tests per day times 6 day a week = 90 x 4 weeks is 360 , we will go low and say 300 tests per month x 12 = 3600 tests per year times $ 1500 = 5.4 million a year , they probly need to do double to start making a profit , how much personel and docters do they need to hire ?, docters being key here , I still feel the company has to have some kind of breakthrough regarding signing up a health care company , firefighters or something along that line and it can be nearly all in house with the tests ,  [using their own personel ] the scientific advisory board will hopefully solve this part of the equation , the company is making progress tho , I have taken up a small position again and waiting to add if the right development gets announced , these of course are rough estimates . GL
<< Previous
Bullboard Posts
Next >>